1. Home
  2. TRX vs CCCC Comparison

TRX vs CCCC Comparison

Compare TRX & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRX
  • CCCC
  • Stock Information
  • Founded
  • TRX 1990
  • CCCC 2015
  • Country
  • TRX Canada
  • CCCC United States
  • Employees
  • TRX N/A
  • CCCC N/A
  • Industry
  • TRX
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRX
  • CCCC Health Care
  • Exchange
  • TRX Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • TRX 90.0M
  • CCCC 104.4M
  • IPO Year
  • TRX N/A
  • CCCC 2020
  • Fundamental
  • Price
  • TRX $0.33
  • CCCC $1.48
  • Analyst Decision
  • TRX Strong Buy
  • CCCC Buy
  • Analyst Count
  • TRX 1
  • CCCC 3
  • Target Price
  • TRX $1.50
  • CCCC $12.00
  • AVG Volume (30 Days)
  • TRX 409.7K
  • CCCC 1.4M
  • Earning Date
  • TRX 07-22-2025
  • CCCC 07-31-2025
  • Dividend Yield
  • TRX N/A
  • CCCC N/A
  • EPS Growth
  • TRX N/A
  • CCCC N/A
  • EPS
  • TRX N/A
  • CCCC N/A
  • Revenue
  • TRX $45,405,000.00
  • CCCC $39,783,000.00
  • Revenue This Year
  • TRX $51.45
  • CCCC N/A
  • Revenue Next Year
  • TRX $26.19
  • CCCC N/A
  • P/E Ratio
  • TRX N/A
  • CCCC N/A
  • Revenue Growth
  • TRX 26.50
  • CCCC 98.56
  • 52 Week Low
  • TRX $0.27
  • CCCC $1.09
  • 52 Week High
  • TRX $0.45
  • CCCC $7.66
  • Technical
  • Relative Strength Index (RSI)
  • TRX 48.65
  • CCCC 48.83
  • Support Level
  • TRX $0.33
  • CCCC $1.36
  • Resistance Level
  • TRX $0.36
  • CCCC $1.60
  • Average True Range (ATR)
  • TRX 0.01
  • CCCC 0.12
  • MACD
  • TRX -0.00
  • CCCC -0.00
  • Stochastic Oscillator
  • TRX 25.00
  • CCCC 31.58

About TRX TRX Gold Corporation

TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: